Important investor notice. On August 3, 2026 the Company received a letter from The Nasdaq Stock Market LLC stating that the Nasdaq Listing Qualifications Staff had determined to delist the Company’s securities under Nasdaq Listing Rules 5101 and IM-5101-4. The Company did not appeal. Trading of the Company’s securities was suspended at the opening of business on August 12, 2026 and a Form 25-NSE was to be filed to remove the securities from listing and registration on Nasdaq. The Company intends to seek quotation of its common stock on the over-the-counter market. The Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and its Quarterly Report on Form 10-Q for the period ended March 31, 2026 have not been filed. Content elsewhere on this site was prepared before these events and is being updated. Read the Form 8-K →

Investors / Why Invest

This page is being updated

The investment overview previously published here was prepared before the events described below and is no longer current. It has been withdrawn pending review.

What has changed. On August 3, 2026 Nasdaq’s Listing Qualifications Staff determined to delist the Company’s securities under Listing Rules 5101 and IM-5101-4, citing the SEC’s October 2025 trading suspension, the Company’s failure to file its Form 10-K for the year ended December 31, 2025 and its Form 10-Q for the period ended March 31, 2026, and public interest concerns arising from the Chapter 11 filing of Society Pass Incorporated, which controls approximately 78% of the Company’s voting power. The Company did not appeal. Trading was suspended at the opening of business on August 12, 2026 and the Company intends to seek quotation on the over-the-counter market.

Investors should rely on the Company’s filings with the U.S. Securities and Exchange Commission rather than on summary materials. The most recent filed periodic report is the Form 10-Q for the quarter ended September 30, 2025.

Read the delisting Form 8-K News & filings